Trial in Progress: A Phase 3, Randomized, Double-Blind Trial of Trilaciclib Versus Placebo in Patients Receiving First- or Second-Line Gemcitabine and Carboplatin for Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (PRESERVE 2).
JOURNAL OF CLINICAL ONCOLOGY（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined